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1,2-sn-Dihexanoylglycefol (HHG) reduced the ATP content of HL-60 cells. This concentration-related (l& 
100 PM) effect reached a maximum of over 90& was enantiomerically specific and not accompanied by 
release of lactate dehydrogenase. Oleoylacetylglycerols (3-100 PM) had no effect on ATP levels while phor- 
bol dibutyrate (PDBu, 0.01-l PM) decreased ATP content of HL-60 cells by up to 40%. Responses stimulated 
by HHG became limited as the concentration was increased above 10 PM, this being manifest as either a 
low maximum response compared to PDBu (superoxide release) or a bell-shaped concentration-effect curve 
(degranulation). HHG (30-100 PM) inhibited PDBu-stimulated superoxide release, this inhibition being 
enantiomerically specific. It is probable that the effect of HHG on ATP content impairs cellular reponses 
mediated through protein kinase C activation. 
Protein kinase C; Phorbol ester; Diacylglycerol; Superoxide; (HL-60 cell) 
1. INTRODUCTION 
Protein kinase C (PKC) is a phospholipid- and 
calcium-dependent enzyme, activated by diacyl- 
glycerols [ 11 and phorbol esters which interact with 
the same ‘receptor’ site on the enzyme [2,3]. 
Diacylglycerols show enantiomeric specificity for 
this site, with the 1,2-sn configuration being 
preferred [4]. Naturally occurring diacylglycerols 
such as 1-stearoyl-2-arachidonoyl-sn-glycerol ac- 
tivate isolated PKC, but such molecules do not 
penetrate cell membranes [5]. Therefore, synthetic 
diacylglycerols that activate PKC in intact cells 
have been sought; such compounds include 1 -oleo- 
yl-2-acetyl-sn-glycerol (OAG) and 1 ,%-dihexanoyl- 
sn-glycerol (HHG) [5-71. This paper compares the 
effects of phorbol dibutyrate (PDBu), OAG and 
HHG on the ATP content of HL-60 granulocytes 
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and illustrates how the decrease of ATP associated 
with HHG may limit the magnitude of cellular 
responses timulated by this PKC activator. 
2. MATERIALS AND METHODS 
The methods used for growth and differentia- 
tion of HL-60 granulocytes, superoxide measure- 
ment and binding of [‘HI phorbol dibutyrate 
([3H]PDBu) were as described previously [8]. Cell 
densities were 0.5 x 106/ml for 02 release and 
ATP measurements, 2-3 x 106/ml for [‘H]PDBu 
binding, and 15 x 106/ml for measurement of & 
glucuronidase release. 
2.1. ATP measurement 
Samples (1 ml) of differentiated HL-60 
granulocytes, prepared as for 01 release ex- 
periments, were incubated with diacylglycerols or 
PDBu for 30 min at 37°C. After sedimentation in 
an Eppendorf microcentrifuge, supernatants were 
removed for measurement of lactate dehydrogen- 
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ase (see below) and 25 ~1 perchloric acid (final con- 
centration 2%) was added to cell pellets. Samples 
were stored at - 20°C until ATP was measured by 
a modification of the method of Stanley and 
Williams [9]. A sample (5 ~1) of each acid extract 
was added to 1 ml freshly prepared buffer (pH 7.4) 
composed of equal amounts of MgS04 (80 mM), 
KHzP04 (10 mM) and NazHAsO4 (100 mM). The 
assay was initiated by the automatic addition of 
luciferin-luciferase (5 mg/ml, Sigma FLE-50) in an 
LKB 125 1 luminometer (integration mode). 
2.2. Lactate dehydrogenase release 
Lactate dehydrogenase (LDH) released into cell 
supernatants was measured by the method of 
Bergmeyer and Bernt [lo]. Portions of cell suspen- 
sions were also incubated with Triton X-100 
(0.1070, w/v) to release total LDH content. 
2.3. &Glucuronidase release 
The release of ,&glucuronidase was measured 
spectrophotometrically, using phenolphthalein 
glucuronide as substrate [111. Total enzyme activi- 
ty was determined in extracts of cells lysed in 
Triton X-100 (0.2%). 
2.4. Synthesis of diacylglycerols 
A mixture of 3-benzyl-sn-glycerol (L-a-O- 
benzoylglycerol, Sigma) (182 mg, 1 mM) and hex- 
anoyl chloride (304 mg, 2.2 mM) in dry toluene 
(2 ml) and dry pyridine (1 ml) was stirred over- 
night at room temperature and evaporated under 
reduced pressure. The residue was partitioned be- 
tween water and ether and the ether layer was 
washed successively with ice-cold 4 M sulphuric 
acid (twice), water, ice-cold saturated NaHCO3 
(twice) and water (twice). The ether solution was 
dried over NazS04 and evaporated to give an oil 
which was purified by flash chromatography in 
ehter/hexane (1: 4) on silica gel (Merck, Kieselgel 
60 art.9385) to give pure 3-benzyl-1,2-dihexanoyl- 
sn-glycerol. This material (220 mg) was deben- 
zylated by hydrogenation in pure tetrahydrofuran 
(35 ml) with 10% palladium on carbon catalyst 
(150 mg). Removal of the catalyst and evaporation 
gave pure 1,2-dihexanoyl-sn-glycerol (160 mg). 
2,3-Dihexanoyl-sn-glycerol was prepared in the 
same way, starting from l-benzyl-sn-glycerol. In 
both cases, thin-layer chromatography and NMR 
spectroscopy (360 MHz) confirmed the absence of 
any 1,3 isomer. 
2.5. Preparation of solutions 
Phorbol dibutyrate (Sigma) was stored as a solu- 
tion (2 mM) in acetone at -20°C. For use, the 
acetone was evaporated and the compound 
redissolved in ethanol (Fisons, Spectrograde) at 
lOOO-times the required final concentration. 
Diacylglycerols were stored at -20°C until use 
when they were also dissolved in dry ethanol at 
lOOO-times the final concentration. Diacylglycerols 
and PDBu were diluted 1: 1000 on addition to cell 
suspensions uch that the ethanol concentration 
did not exceed 0.2% (v/v). 
3. RESULTS AND DISCUSSION 
Concentrations of dihexanoylglycerol (3-100 
PM) that stimulated 02 release from HL-60 cells 
also caused a concentration-dependent fall in 
cellular ATP contents (fig. 1). This effect was enan- 
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Fig. 1. Effect of diacylglycerols and PDBu on the release 
of LDH from (upper panel) and ATP content of (lower 
panel) differentiated HL-60 granulocytes. (A) PDBu, 
(0) 1,2-sn-dihexanoylglycerol, (0) 2,3-sn-dihexanoylgly- 
cerol, (0) 1-oleoyl-2-acetyl-sn-glycerol, ( n ) 3-oleoyl-2- 
acetyl-sn-glycerol. Each point is the mean + SD of 3 
separate determinations. 
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tiomerically specific, with the 1,2-sn enantiomer 
(HHG) being approx. 5-times more effective than 
the 2,3-sn enantiomer. At lOO/rM, HHG de- 
creased the cellular ATP content by 90%. This fall 
in ATP was not associated with a major disruption 
of cells as release of LDH into the supernatant was 
only increased by HHG (1OQrM) to 17% of total, 
compared with 7% release in controls. The release 
of LDH by the dihexanoylglycerols was not enan- 
tiomerically specific (fig.1). In contrast to the 
dihexanoylglycerols, the two enantiomers of 
oleoylacetylglycerol (3-1OOpM) did not cause a 
fall in cellular ATP content. The small increase in 
LDH release caused by these diacylglycerols 
(1OOpM) was, however, comparable to that in- 
duced by HHG. This supports the view that the 
HHG-induced fall in ATP was not due to cell 
disruption. Concentrations of PDBu 
(10 nM-1 /IM) that stimulate 02 release also 
decreased the ATP content of HL-60 cells to a 
minimum of 40% of the control value (fig.1). 
Fig.2 shows concentration-effect curves for 02 
release from HL-60 cells stimulated by PDBu, 
OAG and HHG. The maximum response 
stimulated by PDBu (1 PM) was twice that 
stimulated by HHG. Thus, it is clear that there is 
no direct correlation between the magnitude of 02 
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Fig.2. Stimulation of 0% production from differentiated 
HL-60 granulocytes by increasing concentrations of: 
PBDu (A) HHG (0), OAG (0). Each point represents 
the mean ( f SE) of 6 separate determinations. 
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Fig.3. Displacement of [‘H]PDBu from undifferentiated 
HL-60 cells by increasing concentrations of: PDBu (A), 
HHG (0), OAG (0). Each point represents he mean 
( f SE) of 9 separate determinations. 
release induced by PKC activators and cellular 
ATP content. Therefore, it is unlikely that the fall 
in ATP contributes to the stimulus for 02 genera- 
tion by NADPH oxidase, as was recently suggested 
by Schinetti and Lazzarino [ 121. One possible ex- 
planation for the different maximal 02 responses 
to HHG and PDBu is that HHG is unable to 
penetrate to. sites on PKC in HL-60 cells that are 
accessible to phorbol esters. This interpretation 
was recently used to explain the weak 02 response 
stimulated by OAG [8]. Hbwever, in contrast to 
OAG, HHG completely displaced specifically 
bound [3H]PDBu from HL-60 cells (fig.3). 
Therefore, restricted access to its intracellular 
‘receptor’ on PKC cannot be used to explain the 
low maximum 02 response to HHG. 
When added to HL-60 cells concomitantly with 
PDBu, HHG blocked the 02 response, stimulated 
by this phorbol ester (fig.4). This blocking effect 
occurred with HHG at 30 and 100 pM, concentra- 
tions of the diacylglycerol that decreased cellular 
ATP levels by 55% and 90%, respectively. Fur- 
thermore, the blockade of PDBu-stimulated 0; 
release was enantiomerically specific, 2,3-sn- 
dihexanoylglycerol being inactive. The interaction 
between HHG and PDBu was not competitive 
since increasing the concentration of PDBu to 
lO/rM did not surmount the inhibition by HHG 
100 /rM (not shown). Furthermore, concentration- 
effect curves for activation of isolated PKC by 
HHG and PDBu reached identical maxima, consis- 
tent with the two activators having equal efficacy 
(not shown). Thus, there is no evidence that inhibi- 
tion by HHG of PDBu-stimulated 02 production 
is through antagonism at the PKC ‘receptor’. 
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Fig.4. Stimulation of 0; production from differentiated Fig.5. Release of ,&glucuronidase from differentiated 
HL-60 granulocytes by increasing concentrations of HL-60 granulocytes timulated by increasing concentra- 
1,2-sn-dihexanoylglycerol, HHG (open symbols) or tions of either OAG (0) or HHG (0) added with 
2,3-sn-dihexanoylglycerol (closed symbols) either alone A23187 (0.1 pM). Each point is the mean (f SE) of 3 
(circles) or combined with 100 nM PDBu (squares). The experiments, each in duplicate, expressed as  multiple 
response to PDBu alone is shown by the bar. Each point of the control release stimulated by A23187 alone (5.7 +- 
0.7% of total fi-glucuronidase). is the mean (+ SE) of 6 separate determinations. 
Phorbol esters stimulate degranulation @- 
glucuronidase release) of HL-60 cells, a response 
that also illustrates the synergy between PKC ac- 
tivators and the calcium ionophore A23 187 [ 131. In 
contrast, the diacylglycerols OAG and HHG did 
not directly stimulate degranulation but did 
synergise with A23 187 (fig.5). Degranulation was 
proportional to the concentration of OAG 
(l-100 /cM). However, the concentration-effect 
relationship for HHG was bell-shaped, having an 
optimum at 3 ,uM with degranulation becoming 
significantly less as the concentration was in- 
creased to 30 and 1OOpM. In contrast, the 
concentration-effect curves for degranulation in- 
duced by phorbol esters are sigmoid with asymp- 
totic maxima [ 131. 
In conclusion, this investigation has shown that 
responses of HL-60 cells stimulated by HHG and 
phorbol esters differ qualitatively in two ways: (i) 
the maximum release of Or induced by HHG was 
less than that induced by PDBu; (ii) the degranula- 
tion concentration-effect curve for HHG was bell- 
shaped rather than a rectangular hyperbola [ 131. 
Both observations can be explained by HHG hav- 
ing an effect on HL-60 cells that opposes responses 
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induced by PKC activation, and this is consistent 
with the observed inhibition by HHG of PDBu- 
induced 02 release. It is reasonable to speculate 
that this inhibitory effect is due to the concomitant 
fall of ATP caused by HHG. It is generally be- 
lieved that degranulation of neutrophils requires 
ATP derived from glycolysis [14] as has been 
shown for secretion in other cells, such as the mast 
cell [ 151. Also, release of 02, which requires 
NADPH derived from the pentose phosphate 
pathway, will be impaired by a substantial fall in 
ATP [16]. It is unlikely that a fall in ATP level of 
even 90% will limit protein phosphorylation by the 
kinase itself as the K, of the isolated enzyme for 
ATP is reported to be 5 /IM [ 171. 
The mechanism by which HHG decreased 
cellular ATP is not known. It was not through 
gross cell damage but could be due to increased ion 
permeability of the plasma membrane, so evoking 
increased activity of ion pumps and consequent in- 
creased consumption of ATP. The metabolism of 
HHG by diacylglycerol kinase might also con- 
tribute to a fall in ATP, and would explain the 
enantiomeric specificity of this effect. It would, 
therefore, be interesting to discover the effects of 
174 
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diacylglycerol kinase inhibitors on responses of 
HL-60 cells stimulated by HHG. 
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